Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sunshin Kim
Institution:
National Cancer Center
Observed institutions:
National Cancer Center,
Korea Bioinformation Center,
Korea Research Institute of Bioscience and Biotechnology,
Korea University of Science and Technology
ORCID:
0000-0002-9655-7705
Observed ORCID:
0000-0002-9655-7705
OpenAlex ID:
A5029200393
Molecular Subtypes and Tumor Microenvironment Characteristics of Small-Cell Lung Cancer Associated with Platinum-Resistance
2023
·
Jihyun Kim
, Sunshin Kim
, et al.
·
Cancers
·
17
PDF
Proteogenomic Characterization Reveals Estrogen Signaling as a Target for Never-Smoker Lung Adenocarcinoma Patients without EGFR or ALK Alterations
2024
·
Seung-Jin Park
, Shinyeong Ju
, et al.
·
Cancer Research
·
14
Drug Response of Patient-Derived Lung Cancer Cells Predicts Clinical Outcomes of Targeted Therapy
2024
·
Sunshin Kim
, Youngjoo Lee
, et al.
·
Cancers
·
8
PDF
ATR inhibition promotes synergistic antitumor effect in platinum-resistant pancreatic cancer
2024
·
Jung Won Chun
, Hye Won Shon
, et al.
·
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
·
6
Splicing signature database development to delineate cancer pathways using literature mining and transcriptome machine learning
2023
·
Kyubin Lee
, Daejin Hyung
, et al.
·
Computational and Structural Biotechnology Journal
·
4
Longitudinal pharmacogenomic analysis of refractory lung cancer to identify therapeutic candidates for epidermal growth factor receptor–tyrosine kinase inhibitor resistance subclones
2025
·
Namhee Yu
, Mihwa Hwang
, et al.
·
Experimental & Molecular Medicine
·
3
PDF
Supplementary Figure 1 from Proteogenomic Characterization Reveals Estrogen Signaling as a Target for Never-Smoker Lung Adenocarcinoma Patients without EGFR or ALK Alterations
2024
·
Seung-Jin Park
, Shinyeong Ju
, et al.
Data from Proteogenomic Characterization Reveals Estrogen Signaling as a Target for Never-Smoker Lung Adenocarcinoma Patients without EGFR or ALK Alterations
2024
·
Seung-Jin Park
, Shinyeong Ju
, et al.
Table S12 from Proteogenomic Characterization Reveals Estrogen Signaling as a Target for Never-Smoker Lung Adenocarcinoma Patients without EGFR or ALK Alterations
2024
·
Seung-Jin Park
, Shinyeong Ju
, et al.
Table S7 from Proteogenomic Characterization Reveals Estrogen Signaling as a Target for Never-Smoker Lung Adenocarcinoma Patients without EGFR or ALK Alterations
2024
·
Seung-Jin Park
, Shinyeong Ju
, et al.
Table S6 from Proteogenomic Characterization Reveals Estrogen Signaling as a Target for Never-Smoker Lung Adenocarcinoma Patients without EGFR or ALK Alterations
2024
·
Seung-Jin Park
, Shinyeong Ju
, et al.
Table S8 from Proteogenomic Characterization Reveals Estrogen Signaling as a Target for Never-Smoker Lung Adenocarcinoma Patients without EGFR or ALK Alterations
2024
·
Seung-Jin Park
, Shinyeong Ju
, et al.
Table S12 from Proteogenomic Characterization Reveals Estrogen Signaling as a Target for Never-Smoker Lung Adenocarcinoma Patients without EGFR or ALK Alterations
2024
·
Seung-Jin Park
, Shinyeong Ju
, et al.
Table S9 from Proteogenomic Characterization Reveals Estrogen Signaling as a Target for Never-Smoker Lung Adenocarcinoma Patients without EGFR or ALK Alterations
2024
·
Seung-Jin Park
, Shinyeong Ju
, et al.
Table S5 from Proteogenomic Characterization Reveals Estrogen Signaling as a Target for Never-Smoker Lung Adenocarcinoma Patients without EGFR or ALK Alterations
2024
·
Seung-Jin Park
, Shinyeong Ju
, et al.
Table S3 from Proteogenomic Characterization Reveals Estrogen Signaling as a Target for Never-Smoker Lung Adenocarcinoma Patients without EGFR or ALK Alterations
2024
·
Seung-Jin Park
, Shinyeong Ju
, et al.
Table S6 from Proteogenomic Characterization Reveals Estrogen Signaling as a Target for Never-Smoker Lung Adenocarcinoma Patients without EGFR or ALK Alterations
2024
·
Seung-Jin Park
, Shinyeong Ju
, et al.
Table S2 from Proteogenomic Characterization Reveals Estrogen Signaling as a Target for Never-Smoker Lung Adenocarcinoma Patients without EGFR or ALK Alterations
2024
·
Seung-Jin Park
, Shinyeong Ju
, et al.
Table S4 from Proteogenomic Characterization Reveals Estrogen Signaling as a Target for Never-Smoker Lung Adenocarcinoma Patients without EGFR or ALK Alterations
2024
·
Seung-Jin Park
, Shinyeong Ju
, et al.
Table S1 from Proteogenomic Characterization Reveals Estrogen Signaling as a Target for Never-Smoker Lung Adenocarcinoma Patients without EGFR or ALK Alterations
2024
·
Seung-Jin Park
, Shinyeong Ju
, et al.
Supplementary Figure 3 from Proteogenomic Characterization Reveals Estrogen Signaling as a Target for Never-Smoker Lung Adenocarcinoma Patients without EGFR or ALK Alterations
2024
·
Seung-Jin Park
, Shinyeong Ju
, et al.
Table S14 from Proteogenomic Characterization Reveals Estrogen Signaling as a Target for Never-Smoker Lung Adenocarcinoma Patients without EGFR or ALK Alterations
2024
·
Seung-Jin Park
, Shinyeong Ju
, et al.
Table S2 from Proteogenomic Characterization Reveals Estrogen Signaling as a Target for Never-Smoker Lung Adenocarcinoma Patients without EGFR or ALK Alterations
2024
·
Seung-Jin Park
, Shinyeong Ju
, et al.
Supplementary Figure 2 from Proteogenomic Characterization Reveals Estrogen Signaling as a Target for Never-Smoker Lung Adenocarcinoma Patients without EGFR or ALK Alterations
2024
·
Seung-Jin Park
, Shinyeong Ju
, et al.
Table S13 from Proteogenomic Characterization Reveals Estrogen Signaling as a Target for Never-Smoker Lung Adenocarcinoma Patients without EGFR or ALK Alterations
2024
·
Seung-Jin Park
, Shinyeong Ju
, et al.
Show more works
View as search
Works count:
45
Citation count:
52
H-index:
4
I10-index:
2
Year
Topic
Type